These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 25592801)

  • 1. Management of STEMI in low- and middle-income countries.
    Baliga RR; Bahl VK; Alexander T; Mullasari A; Manga P; Dec GW; Narula J
    Glob Heart; 2014 Dec; 9(4):469-510. PubMed ID: 25592801
    [No Abstract]   [Full Text] [Related]  

  • 2. The chain of survival for ST-segment elevation myocardial infarction: insights into the Middle East.
    El-Deeb MH
    Crit Pathw Cardiol; 2013 Sep; 12(3):154-60. PubMed ID: 23892947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non ST-elevation myocardial infarction: New Zealand management guidelines.
    ;
    N Z Med J; 2005 Oct; 118(1223):U1680. PubMed ID: 16224504
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of acute ST-segment elevation myocardial infarction. II. Beyond reperfusion.
    Glancy DL; Subramaniam PN; Pappas ND; Lewis RS
    J La State Med Soc; 2002; 154(5):235-40; quiz 240. PubMed ID: 12440750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of evidence-based interventions in acute coronary syndrome - Subanalysis of the ACCEPT registry.
    Wang R; Neuenschwander FC; Lima Filho A; Moreira CM; Santos ES; Reis HJ; Romano ER; Mattos LA; Berwanger O; Andrade JP
    Arq Bras Cardiol; 2014 Apr; 102(4):319-26. PubMed ID: 24652052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Unrecognized myocardial infarction].
    Matsumoto T
    Nihon Rinsho; 2007 Sep; Suppl 5 Pt 2():249-52. PubMed ID: 17952999
    [No Abstract]   [Full Text] [Related]  

  • 7. The inflammatory response as a target to reduce myocardial ischaemia and reperfusion injury.
    Steffens S; Montecucco F; Mach F
    Thromb Haemost; 2009 Aug; 102(2):240-7. PubMed ID: 19652874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacotherapy following myocardial infarction].
    Spinarová L; Spinar J; Vítovec J
    Vnitr Lek; 2011 Nov; 57(11):966-9. PubMed ID: 22165705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of atrial fibrillation.
    Kahali D; Mondal S
    J Indian Med Assoc; 2012 May; 110(5):297-301. PubMed ID: 23360021
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical benefit of early reperfusion therapy in patients with ST-elevation myocardial infarction usually excluded from randomized clinical trials (results from the Maximal Individual Therapy in Acute Myocardial Infarction Plus [MITRA Plus] registry).
    Koeth O; Zahn R; Gitt AK; Bauer T; Juenger C; Senges J; Zeymer U;
    Am J Cardiol; 2009 Oct; 104(8):1074-7. PubMed ID: 19801027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacotherapy after cardiac infarction].
    Darius H; Meyer J
    Internist (Berl); 2001 May; 42(5):699-712. PubMed ID: 11400577
    [No Abstract]   [Full Text] [Related]  

  • 12. Re: Secondary medical prevention in patients with peripheral arterial disease.
    Schouten O; Welten GM; Bax JJ; Poldermans D
    Eur J Vasc Endovasc Surg; 2008 Jan; 35(1):59-60. PubMed ID: 17719805
    [No Abstract]   [Full Text] [Related]  

  • 13. Secondary prevention following myocardial infarction: a clinical update.
    Isted A; Williams R; Oakeshott P
    Br J Gen Pract; 2018 Mar; 68(668):151-152. PubMed ID: 29472228
    [No Abstract]   [Full Text] [Related]  

  • 14. Management of acute coronary syndromes.
    Schulman SP; Fessler HE
    Am J Respir Crit Care Med; 2001 Sep; 164(6):917-22. PubMed ID: 11587971
    [No Abstract]   [Full Text] [Related]  

  • 15. Coronary mortality in China: fence, ambulance, or hospital treatments?
    Mensah GA; Sampson UK
    Circ Cardiovasc Qual Outcomes; 2014 Jan; 7(1):8-10. PubMed ID: 24425711
    [No Abstract]   [Full Text] [Related]  

  • 16. Outcome of patients with acute myocardial infarction admitted in hospitals with or without catheterization laboratory: results from the HELIOS registry.
    Pipilis A; Andrikopoulos G; Lekakis J; Kalantzi K; Kitsiou A; Toli K; Floros D; Gaita D; Karalis I; Dragomanovits S; Kalogeropoulos P; Synetos A; Koutsogiannis N; Stougiannos P; Antonakoudis C; Goudevenos J;
    Eur J Cardiovasc Prev Rehabil; 2009 Feb; 16(1):85-90. PubMed ID: 19188809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical management after myocardial infarction.
    Aronow WS
    Future Cardiol; 2019 May; 15(3):135-138. PubMed ID: 31148480
    [No Abstract]   [Full Text] [Related]  

  • 18. [Drug treatment following an infarction].
    Lasserre B; Périat M
    Rev Med Suisse Romande; 1994 Aug; 114(8):677-81. PubMed ID: 7939090
    [No Abstract]   [Full Text] [Related]  

  • 19. Secondary prevention of ischaemic cardiac events.
    Gami A
    Clin Evid; 2006 Jun; (15):195-228. PubMed ID: 16973010
    [No Abstract]   [Full Text] [Related]  

  • 20. Ask the doctor. I had a heart attack three years ago at age 78. My doctor started me on lisinopril, carvedilol, and aspirin. My total cholesterol is 190, and my LDL is 128. Should I be taking a statin?
    Lee R
    Harv Heart Lett; 2011 Aug; 21(12):7. PubMed ID: 21991614
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.